共 16 条
[2]
Significantly higher pathologic complete remission rate after neoadjuvant therapy with trastuzumab, paclitaxel, and epirubicin chemotherapy: Results of a randomized trial in human epidermal growth factor receptor 2-positive operable breast cancer
[J].
JOURNAL OF CLINICAL ONCOLOGY,
2005, 23 (16)
:3676-3685
[3]
CARTER CL, 1989, CANCER-AM CANCER SOC, V63, P181, DOI 10.1002/1097-0142(19890101)63:1<181::AID-CNCR2820630129>3.0.CO
[4]
2-H
[6]
CHEN JH, 2007, ANN M INT SOC MAGN R
[7]
Daling JR, 2002, CANCER EPIDEM BIOMAR, V11, P235
[9]
Machiavelli MR, 1998, CANCER J, V4, P125
[10]
MEHTA RS, 2005, BREAST CANC RES T S1, V29